TRIM2 and nonpapillary renal cell carcinoma: As displayed in Figures 6(c) and 6(d), ccRCC cell proliferation was drastically weakened by miR-146b-5p inhibitor or TRIM2 upregulation, but this effect was reversed after 740Y-P treatment.